AI Revolutionizing Pharmacovigilance: Enhanced Drug Safety Through Machine Intelligence
The world of medicine is constantly evolving, and pharmacovigilance, the science of monitoring drug safety, is no exception. Traditional methods of tracking adverse drug reactions (ADRs) often rely on manual review and passive reporting, which can be slow and miss important signals. This is where Artificial Intelligence (AI) steps in, offering a transformative approach to pharmacovigilance.
PRAC June 2025 Meeting Insights: What It Means & How Vigilare Biopharma Can Help
From Vigilare Biopharma: The recent PRAC meeting (2-5 June 2025) underscores the relentless pace of pharmacovigilance evolution. From gene therapy safety to AI integration and refined risk management for established classes, the demands on sponsors are intensifying. At Vigilare Biopharma, we specialize in transforming complex regulatory signals into actionable, compliant safety strategies.